(Press-News.org) BEER-SHEVA, Israel, March 20, 2013 -- Ben-Gurion University of the Negev (BGU) researchers, in collaboration with Teva Pharmaceutical Industries Ltd., have developed a promising drug candidate to treat psoriasis. The finding was reported in a new paper published in Chemistry and Biology.
Psoriasis is a chronic, non-contagious disease characterized by inflamed lesions covered with silvery-white scabs of dead skin. An auto-immune disease, psoriasis affects at least four million Americans. It is caused by the disturbance in the natural balance between pro-inflammatory signals and signals that inhibit inflammation.
One of the key signals involved in the progression of psoriasis is the immune system protein Interleukin 17 (IL-17). The research team developed a method to inhibit IL-17 pro-inflammatory signals and proved that their engineered receptor, IL-17R, is highly effective in reducing IL-17 induced inflammatory signals in mice models. Moreover, injection of the receptor into a mouse model with acute human psoriasis eliminated the symptoms, essentially curing the disease.
"Using directed evolution to improve the properties of the IL-17 receptor, we have created engineered mutants that might prove there is a viable treatment for patients with severe psoriasis that do not respond to current drugs," explains Dr. Amir Aharoni, one of the researchers in BGU's Department of Life Sciences and the National Institute for Biotechnology in the Negev.
"Since the directed evolution method can be applied to other receptors involved in autoimmune diseases and cancer, I believe that we are just starting to unravel the potential of this approach," Aharoni adds.
Directed evolution is an iterative Darwinian optimization process used in protein engineering whereby the fittest variants are selected from a collection of random mutations. Improved variants are identified and isolated by screening or selection for the property of interest. This approach is particularly advantageous in cases in which no prior knowledge of a protein's mechanism and structure is available.
The other researchers credited in "Directed Evolution of a Soluble Human IL-17A Receptor for the Inhibition of Psoriasis Plaque Formation in a Mouse Model" are BGU's Dr. Marianna Zaretsky and Teva researchers Dr. Liora Sklair-Tavron, Dr. Joel Kaye and Revital Etzyoni.
###
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs, as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in about 60 countries.
American Associates, Ben-Gurion University of the Negev (AABGU) plays a vital role in sustaining David Ben-Gurion's vision, creating a world-class institution of education and research in the Israeli desert, nurturing the Negev community and sharing the University's expertise locally and around the globe. With some 20,000 students on campuses in Beer-Sheva, Sede Boqer and Eilat in Israel's southern desert, BGU is a university with a conscience, where the highest academic standards are integrated with community involvement, committed to sustainable development of the Negev. AABGU is headquartered in Manhattan and has nine regional offices throughout the United States. For more information, please visit http://www.aabgu.org.
Ben-Gurion U. researchers and Teva Pharmaceutical Industries Ltd. develop psoriasis drug
2013-03-20
ELSE PRESS RELEASES FROM THIS DATE:
'End of men'? Not even close
2013-03-20
It's March 2013 – 50 years after Betty Friedan's explosive book launched feminism's "second wave," 41 after Title IX, the equal-opportunity amendment banning sex discrimination in education, was signed into law – and some exceptionally successful women are making a lot of news. Former U.S. Secretary of State Hillary Clinton is riding high in public opinion, winning straw polls for the 2016 presidency. Yahoo CEO Marissa Mayer, after shrugging off maternity leave, has sparked the "Great Telecommuting Debate" with a company-wide ban on working from home. And Sheryl Sandberg, ...
Mechanical forces play key role in assembly and disassembly of an essential cell protein
2013-03-20
Researchers have for the first time demonstrated that mechanical forces can control the depolymerization of actin, a critical protein that provides the major force-bearing structure in the cytoskeletons of cells. The research suggests that forces applied both externally and internally may play a much larger role than previously believed in regulating a range of processes inside cells.
Using atomic force microscopy (AFM) force-clamp experiments, the research found that tensile force regulates the kinetics of actin dissociation by prolonging the lifetimes of bonds at low ...
SMU Lyle School of Engineering course sparks CCL study
2013-03-20
DALLAS (SMU) – The Innovation Gym in SMU's Lyle School of Engineering was buzzing and clanking on a recent morning as students tested robots they built for a specific task – collecting and remediating water samples, as Lyle faculty and students have been doing by hand in refugee camps in Africa and Bangladesh.
The strong work dynamic that emerged among members of the first-year design class and their embrace of the inter-disciplinary team approach used to teach it has drawn the attention of the Center For Creative Leadership, which will send a team of researchers to ...
Altered brain activity responsible for cognitive symptoms of schizophrenia
2013-03-20
Cognitive problems with memory and behavior experienced by individuals with schizophrenia are linked with changes in brain activity; however, it is difficult to test whether these changes are the underlying cause or consequence of these symptoms. By altering the brain activity in mice to mimic the decrease in activity seen in patients with schizophrenia, researchers reporting in the Cell Press journal Neuron on March 20 reveal that these changes in regional brain activity cause similar cognitive problems in otherwise normal mice. This direct demonstration of the link between ...
Some Alaskan trout use flexible guts for the ultimate binge diet
2013-03-20
Imagine having a daylong Thanksgiving feast every day for a month, then, only pauper's rations the rest of the year.
University of Washington researchers have discovered Dolly Varden, a kind of trout, eating just that way in Alaska's Chignik Lake watershed.
Organs such as the stomach and intestines in the Dolly Varden doubled to quadrupled in size when eggs from spawning sockeye salmon became available each August, the researchers found. They were like vacuums sucking up the eggs and nipping at the flesh of spawned-out salmon carcasses.
Then, once the pulse of eggs ...
Spiral beauty graced by fading supernova
2013-03-20
Supernovae are amongst the most violent events in nature. They mark the dazzling deaths of stars and can outshine the combined light of the billions of stars in their host galaxies.
In 1999 the Lick Observatory in California reported the discovery of a new supernova in the spiral galaxy NGC 1637. It was spotted using a telescope that had been specially built to search for these rare, but important cosmic objects [1]. Follow-up observations were requested so that the discovery could be confirmed and studied further. This supernova was widely observed and was given the ...
Estrogen helps keep joint pain at bay after hysterectomy
2013-03-20
CLEVELAND, Ohio (March 20, 2013)—Estrogen therapy can help keep joint pain at bay after menopause for women who have had a hysterectomy. Joint pain was modestly, but significantly, lower in women who took estrogen alone than in women who took placebo in the Women's Health Initiative (WHI) trial. The findings were published online today in Menopause, the journal of The North American Menopause Society.
Studies looking at how estrogen affects joint pain in women after menopause have had mixed results. But this analysis of data on some 1,000 women who had hysterectomies—representative ...
Estrogen may relieve post-menopausal joint pain
2013-03-20
Post-menopausal women, who often suffer from joint pain, could find some long-term relief by taking estrogen-only medication, according to a new study based on the Women's Health Initiative (WHI) that was released online today by the journal, Menopause.
Previous studies of estrogen's influence on joint symptoms had produced mixed results, so researchers examined the findings of the WHI, the largest-ever study of the use of hormonal therapy in post-menopausal women. They examined the findings of the women enrolled in the Estrogen-Alone program, in which women who had undergone ...
Discovery of first motor with revolution motion in a virus-killing bacteria advances nanotechnology
2013-03-20
Scientists have cracked a 35-year-old mystery about the workings of the natural motors that are serving as models for development of a futuristic genre of synthetic nanomotors that pump therapeutic DNA, RNA or drugs into individual diseased cells. Their report revealing the innermost mechanisms of these nanomotors in a bacteria-killing virus — and a new way to move DNA through cells — is being published online today in the journal ACS Nano.
Peixuan Guo and colleagues explain that two motors have been found in nature: A linear motor and a rotating motor. Now they report ...
A milestone for new carbon-dioxide capture/clean coal technology
2013-03-20
An innovative new process that releases the energy in coal without burning — while capturing carbon dioxide, the major greenhouse gas — has passed a milestone on the route to possible commercial use, scientists are reporting. Their study in the ACS journal Energy & Fuels describes results of a successful 200-hour test on a sub-pilot scale version of the technology using two inexpensive but highly polluting forms of coal.
Liang-Shih Fan and colleagues explain that carbon capture and sequestration ranks high among the approaches for reducing coal-related emissions of the ...